A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol ; volume:20 ; number:1 ; day:6 ; month:8 ; year:2020 ; pages:1-9 ; date:12.2020
BMC psychiatry ; 20, Heft 1 (6.8.2020), 1-9, 12.2020
- Urheber
-
Maier, Alice
Dharan, Anita
Oliver, Gina
Berk, Michael
Redston, Suzy
Back, Sudie E.
Kalivas, Peter
Ng, Chee
Kanaan, Richard A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12888-020-02793-9
- URN
-
urn:nbn:de:101:1-2020100120104912558578
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-14T10:48:57+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maier, Alice
- Dharan, Anita
- Oliver, Gina
- Berk, Michael
- Redston, Suzy
- Back, Sudie E.
- Kalivas, Peter
- Ng, Chee
- Kanaan, Richard A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
Tobacco smoking predicts depression and poorer quality of life in heart disease
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
Tobacco smoking predicts depression and poorer quality of life in heart disease
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
Tobacco smoking predicts depression and poorer quality of life in heart disease